Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000950170-25-058810·Caribou Biosciences, Inc.
Schedule 13D ownership disclosure
Caribou Biosciences Inc
Common stock, par value $0.0001 per share · CUSIP: 142038108
Event date: 2025-04-22
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- The City Canyon Family Trust dated May 31, 2021
Shares: 3,369,395 · Class: 3.6%
- Rachel E. HaurwitzReported CIK 0001670579
Shares: 4,716,003 · Class: 5%
- Felix Adler
Shares: 4,716,003 · Class: 5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-058810
- Form type
- SCHEDULE 13D
- Filer
- Caribou Biosciences, Inc.
- CIK
- CIK 1619856
- Filed
- Apr 25, 2025
- Reporting period
- Apr 22, 2025
- Description
- Schedule 13D beneficial ownership